Table 2.
Distribution of individual EBV antigen antibody titers with demographic characteristics (n, %)
| VCA | EBNA | EA | ZEBRA | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|||||||||||||
| < 25th | 25th–75th | >75th | P* | < 25th | 25th–75th | >75th | P* | < 25th | 25th– 75th | >75th | P* | < 25th | 25th– 75th | >75th | P* | |
| Sex | 0.003 | 0.06 | < 0.0001 | < 0.0001 | ||||||||||||
| Female | 354 (43.12) | 786 (48.76) | 409 (50.43) | 407 (48.34) | 794 (49.50) | 348 (43.61) | 307 (37.39) | 803 (49.91) | 439 (53.93) | 291 | 815 | 443 | ||||
| Male | 467 (56.88) | 826 (51.24) | 402 (49.57) | 435 (51.66) | 810 (50.50) | 450 (56.39) | 514 (62.61) | 806 (50.09) | 375 (46.07) | 564 (65.96) | 764 (48.39) | 367 (45.31) | ||||
| Age | < 0.0001 | 0.24 | < 0.0001 | < 0.0001 | ||||||||||||
| ≤ 45 Years | 126 (15.35) | 172 (10.67) | 69 (8.50) | 103 (12.23) | 169 (10.54) | 95 (11.90) | 107 (13.03) | 197 (12.24) | 63 (7.74) | 118 (13.80) | 180 (11.40) | 69 (8.52) | ||||
| 45–55 | 250 (30.45) | 464 (28.78) | 217 (26.76) | 249 (29.57) | 441 (27.49) | 241 (30.20) | 254 (30.94) | 465 (28.90) | 212 (26.04) | 253 (29.59) | 470 (29.77) | 208 (25.68) | ||||
| 56–65 | 282 (34.35) | 565 (35.05) | 272 (33.54) | 313 (37.17) | 554 (34.54) | 252 (31.58) | 269 (32.76) | 568 (35.30) | 282 (34.64) | 286 (33.45) | 526 (33.31) | 307 (37.90) | ||||
| > 65 | 163 (19.85) | 411 (25.50) | 253 (31.20) | 177 (21.03) | 440 (27.43) | 210 (26.32) | 191 (23.26) | 379 (23.56) | 257 (31.58) | 198 (23.16) | 403 (25.52) | 226 (27.90) | ||||
| Smoke | 0.15 | < 0.01 | 0.03 | 0.01 | ||||||||||||
| Never | 460 (56.03) | 973 (60.36) | 470 (58.02) | 517 (61.40) | 954 (59.51) | 432 (54.14) | 448 (54.57) | 968 (60.20) | 487 (59.83) | 450 (52.69) | 963 (60.99) | 490 (60.49) | ||||
| Former | 98 (11.94) | 187 (11.60) | 115 (14.20) | 85 (10.10) | 188 (11.73) | 127 (15.91) | 108 (13.15) | 195 (12.13) | 97 (11.92) | 115 (13.47) | 206 (13.05) | 79 (9.75) | ||||
| Current | 263 (32.03) | 452 (28.04) | 225 (27.78) | 240 (28.50) | 461 (28.76) | 239 (29.95) | 265 (32.28) | 445 (27.67) | 230 (28.26) | 289 (33.84) | 410 (25.97) | 241 (29.75) | ||||
| H. pylori | 0.12 | 0.95 | 0.03 | 0.03 | ||||||||||||
| Negative | 118 (14.37) | 237 (14.70) | 95 (11.71) | 110 (13.06) | 237 (14.78) | 103 (12.91) | 133 (16.20) | 215 (13.36) | 102 (12.53) | 131 (15.32) | 224 (14.19) | 95 (11.73) | ||||
| Positive | 703 (85.63) | 1375 (85.30) | 716 (88.29) | 732 (86.94) | 1367 (85.22) | 695 (87.09) | 688 (83.80) | 1394 (86.64) | 712 (87.47) | 724 (84.68) | 1355 (85.81) | 715 (88.27) | ||||
| Omp and HP0305 status | 0.58 | 0.65 | 0.68 | 0.18 | ||||||||||||
| Omp− and HP0305− | 144 (17.54) | 272 (16.87) | 134 (16.52) | 133 (15.80) | 278 (17.33) | 139 (17.42) | 141 (17.17) | 268 (16.66) | 141 (17.32) | 139 (16.26) | 277 (17.54) | 134 (16.54) | ||||
| Omp + or HP0305+ | 216 (26.31) | 434 (26.92) | 213 (26.26) | 213 (25.30) | 448 (27.93) | 202 (25.31) | 230 (28.01) | 420 (26.10) | 213 (26.17) | 245 (28.65) | 418 (26.47) | 200 (24.69) | ||||
| Omp + and HP0305+ | 461 (56.15) | 906 (56.21) | 464 (57.22) | 496 (58.90) | 878 (54.74) | 457 (57.27) | 450 (54.81) | 921 (57.24) | 460 (56.51) | 471 (55.09) | 884 (55.98) | 476 (58.77) | ||||
*
Cochran Mantel–Haenszel Chi